What does Marinus Pharmaceuticals, Inc. do?

Jun 22 2025 06:46 PM IST
share
Share Via
Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for epilepsy and neuropsychiatric disorders. As of September 2024, it reported net sales of $9 million and a net loss of $24 million, with a market cap of $30.37 million.
Overview:
Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for epilepsy and neuropsychiatric disorders, operating within the Pharmaceuticals: Major industry and classified as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 9 Million (Quarterly Results - Sep 2024)
Most recent Net Profit: -24 Million (Quarterly Results - Sep 2024)
Market cap: USD 30.37 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 91.65%
Debt Equity: -0.79
Return on Equity: 207.58%
Price to Book: -0.46

Contact Details:
Address: 5 Radnor Corporate Center Suite 500, 100 Matsonford Rd RADNOR PA : 19087
Tel: 1 484 8014670
Fax: 1 302 6555049
Website: http://www.marinuspharma.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is Marinus Pharmaceuticals, Inc.?
Jun 22 2025 06:03 PM IST
share
Share Via